bluuebunny/crossref_metadata_2025 huggingface dataset:
Supplementary Figure 3 from Population Pharmacokinetics of Busulfan in Children: Increased Evidence for Body Surface Area and Allometric Body Weight Dosing of Busulfan in Children
Authors: Trame Mirjam N. , Bergstrand Martin , Karlsson Mats O. , Boos Joachim , Hempel Georg
Published: April 2023

PDF file - 143KB, Goodness-of-fit plots: (A,B) evaluation dataset with allometric body weight as covariate on clearance; (C,D) evaluation dataset with body surface area as covariate on clearance. For each dataset the observed plasma concentrations are plotted against the population model predicted concentrations and against the individual model predicted concentrations. The line of identity is shown.
Supplementary Figure 3 from MiR-1 Downregulation Cooperates with MACC1 in Promoting MET Overexpression in Human Colon Cancer
Authors: Migliore Cristina , Martin Valentina , Leoni Vera P. , Restivo Angelo , Atzori Luigi , Petrelli Annalisa , Isella Claudio , Zorcolo Luigi , Sarotto Ivana , Casula Giuseppe , Comoglio Paolo M. , Columbano Amedeo , Giordano Silvia
Published: April 2023

PDF file - 275K
Supplementary Figure Legends 1-5 from PTEN Deletion in Prostate Cancer Cells Does Not Associate with Loss of RAD51 Function: Implications for Radiotherapy and Chemotherapy
Authors: Fraser Michael , Zhao Helen , Luoto Kaisa R. , Lundin Cecilia , Coackley Carla , Chan Norman , Joshua Anthony M. , Bismar Tarek A. , Evans Andrew , Helleday Thomas , Bristow Robert G.
Published: April 2023

PDF file - 89K
Supplementary Figure 4 from PTEN Deletion in Prostate Cancer Cells Does Not Associate with Loss of RAD51 Function: Implications for Radiotherapy and Chemotherapy
Authors: Fraser Michael , Zhao Helen , Luoto Kaisa R. , Lundin Cecilia , Coackley Carla , Chan Norman , Joshua Anthony M. , Bismar Tarek A. , Evans Andrew , Helleday Thomas , Bristow Robert G.
Published: April 2023

PDF file - 183K
Supplementary Figure 3 from PTEN Deletion in Prostate Cancer Cells Does Not Associate with Loss of RAD51 Function: Implications for Radiotherapy and Chemotherapy
Authors: Fraser Michael , Zhao Helen , Luoto Kaisa R. , Lundin Cecilia , Coackley Carla , Chan Norman , Joshua Anthony M. , Bismar Tarek A. , Evans Andrew , Helleday Thomas , Bristow Robert G.
Published: April 2023

PDF file - 33K
Supplementary Table 4 from Genome-Wide CpG Island Profiling of Intraductal Papillary Mucinous Neoplasms of the Pancreas
Authors: Hong Seung-Mo , Omura Noriyuki , Vincent Audrey , Li Ang , Knight Spencer , Yu Jun , Hruban Ralph H. , Goggins Michael
Published: April 2023

XLS file - 232K
Supplementary Figure 1 from PTEN Deletion in Prostate Cancer Cells Does Not Associate with Loss of RAD51 Function: Implications for Radiotherapy and Chemotherapy
Authors: Fraser Michael , Zhao Helen , Luoto Kaisa R. , Lundin Cecilia , Coackley Carla , Chan Norman , Joshua Anthony M. , Bismar Tarek A. , Evans Andrew , Helleday Thomas , Bristow Robert G.
Published: April 2023

PDF file - 88K
Supplementary Table 3 from Genome-Wide CpG Island Profiling of Intraductal Papillary Mucinous Neoplasms of the Pancreas
Authors: Hong Seung-Mo , Omura Noriyuki , Vincent Audrey , Li Ang , Knight Spencer , Yu Jun , Hruban Ralph H. , Goggins Michael
Published: April 2023

XLS file - 461K
Supplementary Table 2 from Genome-Wide CpG Island Profiling of Intraductal Papillary Mucinous Neoplasms of the Pancreas
Authors: Hong Seung-Mo , Omura Noriyuki , Vincent Audrey , Li Ang , Knight Spencer , Yu Jun , Hruban Ralph H. , Goggins Michael
Published: April 2023

XLS file - 13K
Supplementary Tables 1-2 from Membranous Expression of Ectodomain Isoforms of the Epidermal Growth Factor Receptor Predicts Outcome after Chemoradiotherapy of Lymph Node–Negative Cervical Cancer
Authors: Halle Cathinka , Lando Malin , Svendsrud Debbie Hege , Clancy Trevor , Holden Marit , Sundfør Kolbein , Kristensen Gunnar B. , Holm Ruth , Lyng Heidi
Published: April 2023

PDF file - 23K, Patient and tumor characteristics of the validation cohort and by lymph node status of the basic cohort.
Supplementary Figure Legends 1-5 from Genome-Wide CpG Island Profiling of Intraductal Papillary Mucinous Neoplasms of the Pancreas
Authors: Hong Seung-Mo , Omura Noriyuki , Vincent Audrey , Li Ang , Knight Spencer , Yu Jun , Hruban Ralph H. , Goggins Michael
Published: April 2023

PDF file - 68K
Supplementary Figure 1 from Membranous Expression of Ectodomain Isoforms of the Epidermal Growth Factor Receptor Predicts Outcome after Chemoradiotherapy of Lymph Node–Negative Cervical Cancer
Authors: Halle Cathinka , Lando Malin , Svendsrud Debbie Hege , Clancy Trevor , Holden Marit , Sundfør Kolbein , Kristensen Gunnar B. , Holm Ruth , Lyng Heidi
Published: April 2023

PDF file - 212K
Supplementary Figure 2 from Genome-Wide CpG Island Profiling of Intraductal Papillary Mucinous Neoplasms of the Pancreas
Authors: Hong Seung-Mo , Omura Noriyuki , Vincent Audrey , Li Ang , Knight Spencer , Yu Jun , Hruban Ralph H. , Goggins Michael
Published: April 2023

PDF file - 76K
Supplementary Figure 1 from Genome-Wide CpG Island Profiling of Intraductal Papillary Mucinous Neoplasms of the Pancreas
Authors: Hong Seung-Mo , Omura Noriyuki , Vincent Audrey , Li Ang , Knight Spencer , Yu Jun , Hruban Ralph H. , Goggins Michael
Published: April 2023

PDF file - 694K
Supplementary Table 6 from Integrative Genomic Analysis Implicates Gain of PIK3CA at 3q26 and MYC at 8q24 in Chronic Lymphocytic Leukemia
Authors: Brown Jennifer R. , Hanna Megan , Tesar Bethany , Werner Lillian , Pochet Nathalie , Asara John M. , Wang Yaoyu E. , dal Cin Paola , Fernandes Stacey M. , Thompson Christina , MacConaill Laura , Wu Catherine J. , Van de Peer Yves , Correll Mick , Regev Aviv , Neuberg Donna , Freedman Arnold S.
Published: April 2023

XLS file, 1603KB.
Supplementary Figure Legends from Phase II, Open-Label Study of Brivanib as Second-Line Therapy in Patients with Advanced Hepatocellular Carcinoma
Authors: Finn Richard S. , Kang Yoon-Koo , Mulcahy Mary , Polite Blase N. , Lim Ho Yeong , Walters Ian , Baudelet Christine , Manekas Demetrios , Park Joong-Won
Published: April 2023

PDF file - 58K
Supplementary Figure 1 from Phase II, Open-Label Study of Brivanib as Second-Line Therapy in Patients with Advanced Hepatocellular Carcinoma
Authors: Finn Richard S. , Kang Yoon-Koo , Mulcahy Mary , Polite Blase N. , Lim Ho Yeong , Walters Ian , Baudelet Christine , Manekas Demetrios , Park Joong-Won
Published: April 2023

PDF file - 35K
CCR Translation for This Article from Phase II, Open-Label Study of Brivanib as Second-Line Therapy in Patients with Advanced Hepatocellular Carcinoma
Authors: Finn Richard S. , Kang Yoon-Koo , Mulcahy Mary , Polite Blase N. , Lim Ho Yeong , Walters Ian , Baudelet Christine , Manekas Demetrios , Park Joong-Won
Published: April 2023

CCR Translation for This Article from Phase II, Open-Label Study of Brivanib as Second-Line Therapy in Patients with Advanced Hepatocellular Carcinoma
Supplementary Figure 3 from To DNA or not to DNA? That Is the Question, When It Comes to Molecular Subtyping for the Clinic!
Authors: Smeets Serge J. , Harjes Ulrike , van Wieringen Wessel N. , Sie Daoud , Brakenhoff Ruud H. , Meijer Gerrit A. , Ylstra Bauke
Published: April 2023

PDF file - 7.64 MB
Table 5 from Quantitative Cell-Free DNA, KRAS, and BRAF Mutations in Plasma from Patients with Metastatic Colorectal Cancer during Treatment with Cetuximab and Irinotecan
Authors: Spindler Karen-Lise Garm , Pallisgaard Niels , Vogelius Ivan , Jakobsen Anders
Published: April 2023

PDF file - 52K
Supplementary Figure 1 from To DNA or not to DNA? That Is the Question, When It Comes to Molecular Subtyping for the Clinic!
Authors: Smeets Serge J. , Harjes Ulrike , van Wieringen Wessel N. , Sie Daoud , Brakenhoff Ruud H. , Meijer Gerrit A. , Ylstra Bauke
Published: April 2023

PDF file - 1.94 MB
Supplementary Methods from Microarray Analysis of Colorectal Cancer Stromal Tissue Reveals Upregulation of Two Oncogenic miRNA Clusters
Authors: Nishida Naohiro , Nagahara Makoto , Sato Tetsuya , Mimori Koshi , Sudo Tomoya , Tanaka Fumiaki , Shibata Kohei , Ishii Hideshi , Sugihara Kenichi , Doki Yuichiro , Mori Masaki
Published: April 2023

PDF file, 12KB.
Supplementary Figure 2B from Microarray Analysis of Colorectal Cancer Stromal Tissue Reveals Upregulation of Two Oncogenic miRNA Clusters
Authors: Nishida Naohiro , Nagahara Makoto , Sato Tetsuya , Mimori Koshi , Sudo Tomoya , Tanaka Fumiaki , Shibata Kohei , Ishii Hideshi , Sugihara Kenichi , Doki Yuichiro , Mori Masaki
Published: April 2023

PDF file, 63KB, Cluster Dendrogram. All components of the miR-17-92a cluster and the miR-106b-25 cluster except miR-92a is classified in Cluster 2 (middle). On the other hand, miR-92a was classified in Cluster 3(Right).
Supplementary Tables 1-8 from Prognostic Role of PIK3CA Mutation in Colorectal Cancer: Cohort Study and Literature Review
Authors: Liao Xiaoyun , Morikawa Teppei , Lochhead Paul , Imamura Yu , Kuchiba Aya , Yamauchi Mai , Nosho Katsuhiko , Qian Zhi Rong , Nishihara Reiko , Meyerhardt Jeffrey A. , Fuchs Charles S. , Ogino Shuji
Published: April 2023

PDF file - 98K
Supplementary Figure 7 from Modulation of NOXA and MCL-1 as a Strategy for Sensitizing Melanoma Cells to the BH3-Mimetic ABT-737
Authors: Lucas Keryn M. , Mohana-Kumaran Nethia , Lau Diana , Zhang Xu Dong , Hersey Peter , Huang David C. , Weninger Wolfgang , Haass Nikolas K. , Allen John D.
Published: April 2023

PDF file - 7.8MB, Effects of ABT-737 on growth of 3D melanoma spheroids derived from C8161/NOXA clone C6 (A) ABT-737 was applied at the concentrations shown for 3 days. Note the dose-dependent inhibition of proliferation and invasion as well as decrease of viable cells (calcein-AM) and increase of dead cells (ethidium bromide). Bar: 500 �m. (B) Untreated spheroids; (C) treated with ABT-737 from day 0 at the concentrations shown with replenishment every 3 days for 10 days or (D) treated likewise from day 7. Bars: 500 �m.
Supplementary Figure 5 from Modulation of NOXA and MCL-1 as a Strategy for Sensitizing Melanoma Cells to the BH3-Mimetic ABT-737
Authors: Lucas Keryn M. , Mohana-Kumaran Nethia , Lau Diana , Zhang Xu Dong , Hersey Peter , Huang David C. , Weninger Wolfgang , Haass Nikolas K. , Allen John D.
Published: April 2023

PDF file - 1.3MB, Growth of xenografts, where the hosts were treated i.p. with 75 mg/kg ABT-737 or vehicle daily from 7 days post-engraftment for 21 days, 10 mice/group.
Supplementary Figures 1-6, Table 1 from Toward the Prognostic Significance and Therapeutic Potential of HER3 Receptor Tyrosine Kinase in Human Colon Cancer
Authors: Beji Abdelhamid , Horst David , Engel Jutta , Kirchner Thomas , Ullrich Axel
Published: April 2023

PDF file - 1.5MB
Supplementary Figure 2 from Peptides Mimicking the Unique ARTS-XIAP Binding Site Promote Apoptotic Cell Death in Cultured Cancer Cells
Authors: Edison Natalia , Reingewertz Tali-Haviv , Gottfried Yossi , Lev Tali , Zuri Dotan , Maniv Inbal , Carp Marie-Jeanne , Shalev Gil , Friedler Assaf , Larisch Sarit
Published: April 2023

PDF file - 2.2MB
Supplementary Figure 1 from Connexin 47 Mutations Increase Risk for Secondary Lymphedema Following Breast Cancer Treatment
Authors: Finegold David N. , Baty Catherine J. , Knickelbein Kelly Z. , Perschke Shelley , Noon Sarah E. , Campbell Diana , Karlsson Jenny M. , Huang Diana , Kimak Mark A. , Lawrence Elizabeth C. , Feingold Eleanor , Meriney Stephen D. , Brufsky Adam M. , Ferrell Robert E.
Published: April 2023

PDF file - 170K, Representative LEC microingjections showing dye transfer. Pre-images obtained using DIC and gfp (a,c,e) showing dsred (pink) for reference cell and lucifer yellow dye transfer in blue. LECs electroporated with empty EGFP vector (a,b); WT- hCx47-EGFP (c,d); H409Y-EGFP (e,f). 40x oil, 1.3 n.a.
Supplementary Table 2 from Phase I Study of the Combination of Sorafenib and Temsirolimus in Patients with Metastatic Melanoma
Authors: Davies Michael A. , Fox Patricia S. , Papadopoulos Nicholas E. , Bedikian Agop Y. , Hwu Wen-Jen , Lazar Alexander J. , Prieto Victor G. , Culotta Kirk S. , Madden Timothy L. , Xu Quanyun , Huang Sha , Deng Wanleng , Ng Chaan S. , Gupta Sanjay , Liu Wenbin , Dancey Janet E. , Wright John J. , Bassett Roland L. , Hwu Patrick , Kim Kevin B.
Published: April 2023

PDF file - 70K
Supplementary Materials and Methods from Phase I Study of the Combination of Sorafenib and Temsirolimus in Patients with Metastatic Melanoma
Authors: Davies Michael A. , Fox Patricia S. , Papadopoulos Nicholas E. , Bedikian Agop Y. , Hwu Wen-Jen , Lazar Alexander J. , Prieto Victor G. , Culotta Kirk S. , Madden Timothy L. , Xu Quanyun , Huang Sha , Deng Wanleng , Ng Chaan S. , Gupta Sanjay , Liu Wenbin , Dancey Janet E. , Wright John J. , Bassett Roland L. , Hwu Patrick , Kim Kevin B.
Published: April 2023

PDF file - 43K
Supplementary Figure 1 from Histone Deacetylase Inhibitors Induce Growth Arrest and Differentiation in Uveal Melanoma
Authors: Landreville Solange , Agapova Olga A. , Matatall Katie A. , Kneass Zachary T. , Onken Michael D. , Lee Ryan S. , Bowcock Anne M. , Harbour J. William
Published: April 2023

PDF file - 2.3MB
Supplementary Figure 2 from Regulation of CD20 in Rituximab-Resistant Cell Lines and B-cell Non-Hodgkin Lymphoma
Authors: Tsai Ping-Chiao , Hernandez-Ilizaliturri Francisco J. , Bangia Naveen , Olejniczak Scott H. , Czuczman Myron S.
Published: April 2023

PDF file - 101K
Supplementary Table 2 from Telomerase Peptide Vaccination in NSCLC: A Phase II Trial in Stage III Patients Vaccinated after Chemoradiotherapy and an 8-Year Update on a Phase I/II Trial
Authors: Brunsvig Paal Fr. , Kyte Jon Amund , Kersten Christian , Sundstrøm Stein , Møller Mona , Nyakas Marta , Hansen Gaute L. , Gaudernack Gustav , Aamdal Steinar
Published: April 2023

PDF file - 16KB
Supplementary Table 1 from Telomerase Peptide Vaccination in NSCLC: A Phase II Trial in Stage III Patients Vaccinated after Chemoradiotherapy and an 8-Year Update on a Phase I/II Trial
Authors: Brunsvig Paal Fr. , Kyte Jon Amund , Kersten Christian , Sundstrøm Stein , Møller Mona , Nyakas Marta , Hansen Gaute L. , Gaudernack Gustav , Aamdal Steinar
Published: April 2023

PDF file - 17KB
Supplementary Figure 2 from Targeting Tumor-Associated Endothelial Cells: Anti-VEGFR2 Immunoliposomes Mediate Tumor Vessel Disruption and Inhibit Tumor Growth
Authors: Wicki Andreas , Rochlitz Christoph , Orleth Annette , Ritschard Reto , Albrecht Imke , Herrmann Richard , Christofori Gerhard , Mamot Christoph
Published: April 2023

PDF file - 208K, (A) VEGFR2 is selectively expressed in tumor blood endothelial cells (BECs). Single cell suspension of pancreatic tumors of 12 weeks old Rip1Tag2 mice were prepared by Dispase digestion. For subsequent isolation of GLP-1R+ �-tumor cells (TC) and tumor-derived CD31+ blood vessel endothelial cells (BEC) by fluorescence-activated cell sorting (FACS), cells were stained with FITC-labeled glucagon-like peptide 1 receptor (GLP-1R) peptide ligand exendin-4 and with APC-CD31. Quantitative RT-PCR analysis verified VEGFR2 expression in CD31-positive BECs but not in TC. Cultured MS-1 cells express low levels of VEGFR2. (B) VEGFR2 is expressed in tumor-associated microvessels. Immunofluorescence staining of vessels in the pancreas of a Rip1Tag2 mouse treated with PLD. VEGFR2 is expressed in microvessels, but not in larger vessels or mature vessels. Vessels in the exocrine pancreas express lower levels of VEGFR2. Bar, 100 �m. The tumor tissue is delineated with a white line. Green = staining with anti-CD31, red = staining with anti-VEGFR2, blue = DAPI. Merge= overlay of single stainings.
Supplementary Figure 8 from Downregulation of SMG-1 in HPV-Positive Head and Neck Squamous Cell Carcinoma Due to Promoter Hypermethylation Correlates with Improved Survival
Authors: Gubanova Evgenia , Brown Brandee , Ivanov Sergei V. , Helleday Thomas , Mills Gordon B. , Yarbrough Wendell G. , Issaeva Natalia
Published: April 2023

PDF file - 1.5MB
Supplementary Tables 1-3 from Clarifying the Spectrum of Driver Oncogene Mutations in Biomarker-Verified Squamous Carcinoma of Lung: Lack of EGFR/KRAS and Presence of PIK3CA/AKT1 Mutations
Authors: Rekhtman Natasha , Paik Paul K. , Arcila Maria E. , Tafe Laura J. , Oxnard Geoffrey R. , Moreira Andre L. , Travis William D. , Zakowski Maureen F. , Kris Mark G. , Ladanyi Marc
Published: April 2023

PDF file - 95K
Supplementary Figures 1-2 from Evaluation of Circulating Tumor Cells and Circulating Tumor DNA in Non–Small Cell Lung Cancer: Association with Clinical Endpoints in a Phase II Clinical Trial of Pertuzumab and Erlotinib
Authors: Punnoose Elizabeth A. , Atwal Siminder , Liu Weiqun , Raja Rajiv , Fine Bernard M. , Hughes Brett G.M. , Hicks Rodney J. , Hampton Garret M. , Amler Lukas C. , Pirzkall Andrea , Lackner Mark R.
Published: April 2023

PDF file - 337K
Supplementary Figure 2 from Downregulation of SMG-1 in HPV-Positive Head and Neck Squamous Cell Carcinoma Due to Promoter Hypermethylation Correlates with Improved Survival
Authors: Gubanova Evgenia , Brown Brandee , Ivanov Sergei V. , Helleday Thomas , Mills Gordon B. , Yarbrough Wendell G. , Issaeva Natalia
Published: April 2023

PDF file - 3.2MB
Supplementary Tables 1-6 from Correlation of ERG Expression and DNA Methylation Biomarkers with Adverse Clinicopathologic Features of Prostate Cancer
Authors: Kron Ken , Liu Liyang , Trudel Dominique , Pethe Vaijayanti , Trachtenberg John , Fleshner Neil , Bapat Bharati , van der Kwast Theodorus
Published: April 2023

XLS file, 44KB.
Supplementary Data from Modulators of Arginine Metabolism Do Not Impact on Peripheral T-Cell Tolerance and Disease Progression in a Model of Spontaneous Prostate Cancer
Authors: Rigamonti Nicolò , Capuano Giusy , Ricupito Alessia , Jachetti Elena , Grioni Matteo , Generoso Luca , Freschi Massimo , Bellone Matteo
Published: April 2023

Supplementary Figures S1-S8.
Supplementary Table from External Validation of Diagnostic Models to Estimate the Risk of Malignancy in Adnexal Masses
Authors: Van Holsbeke Caroline , Van Calster Ben , Bourne Tom , Ajossa Silvia , Testa Antonia C. , Guerriero Stefano , Fruscio Robert , Lissoni Andrea Alberto , Czekierdowski Artur , Savelli Luca , Van Huffel Sabine , Valentin Lil , Timmerman Dirk
Published: April 2023

PDF file - 94K
Supplementary Figures 1 - 3 from SSBP2 Variants Are Associated with Survival in Glioblastoma Patients
Authors: Xiao Yuanyuan , Decker Paul A. , Rice Terri , McCoy Lucie S. , Smirnov Ivan , Patoka Joseph S. , Hansen Helen M. , Wiemels Joe L. , Tihan Tarik , Prados Michael D. , Chang Susan M. , Berger Mitchel S. , Kosel Matthew L. , Fridley Brooke L. , Lachance Daniel H. , O'Neill Brian Patrick , Buckner Jan C. , Thompson Reid C. , Nabors Louis Burt , Olson Jeffrey J. , Brem Steve , Madden Melissa H. , Browning James E. , Wiencke John K. , Egan Kathleen M. , Jenkins Robert B. , Wrensch Margaret R.
Published: April 2023

PDF file, 333KB, Figure 1a: Genome-wide Constitutive SNP Analysis with GBM Patient Overall Survival, Figure 1b: Association of Gene Expression in Tumors with Overall GBM Patient Survival.
Supplementary Tables 1-2, Figures 1-3 from Tumor Epidermal Growth Factor Receptor and EGFR PY1068 Are Independent Prognostic Indicators for Head and Neck Squamous Cell Carcinoma
Authors: Wheeler Sarah , Siwak Doris R. , Chai Raymond , LaValle Courtney , Seethala Raja R. , Wang Lin , Cieply Kathleen , Sherer Carol , Joy Corwin , Mills Gordon B. , Argiris Athanassios , Siegfried Jill M. , Grandis Jennifer R. , Egloff Ann Marie
Published: April 2023

PDF file - 1.2MB, t of Supplemental Materials Supplemental Table 1. EDRN Cohort Characteristics by HPV Status Supplemental Table 2. EDRN Cohort Tumor Molecular Correlates by HPV Status Supplemental Figure 1. RPPA results were validated by immunoblotting analysis. Supplemental Figure 2. Representative EGFR IHC stained tumor cores from the cetuximab-treated cohort.
Supplementary Table 2 from Integrative Survival-Based Molecular Profiling of Human Pancreatic Cancer
Authors: Donahue Timothy R. , Tran Linh M. , Hill Reginald , Li Yunfeng , Kovochich Anne , Calvopina Joseph H. , Patel Sanjeet G. , Wu Nanping , Hindoyan Antreas , Farrell James J. , Li Xinmin , Dawson David W. , Wu Hong
Published: April 2023

PDF file - 325K
Supplementary Methods, Figure Legends 1-3, Tables 1, 3, 4, 6 from Integrative Survival-Based Molecular Profiling of Human Pancreatic Cancer
Authors: Donahue Timothy R. , Tran Linh M. , Hill Reginald , Li Yunfeng , Kovochich Anne , Calvopina Joseph H. , Patel Sanjeet G. , Wu Nanping , Hindoyan Antreas , Farrell James J. , Li Xinmin , Dawson David W. , Wu Hong
Published: April 2023

PDF file - 197K
Related Article from Biology, Models, and the Analysis of Tumor Xenograft Experiments
Authors: Heitjan Daniel F.
Published: April 2023

Related Article from Biology, Models, and the Analysis of Tumor Xenograft Experiments
Supplementary Report from Robust Gene Expression Signature from Formalin-Fixed Paraffin-Embedded Samples Predicts Prognosis of Non–Small-Cell Lung Cancer Patients
Authors: Xie Yang , Xiao Guanghua , Coombes Kevin R. , Behrens Carmen , Solis Luisa M. , Raso Gabriela , Girard Luc , Erickson Heidi S. , Roth Jack , Heymach John V. , Moran Cesar , Danenberg Kathy , Minna John D. , Wistuba Ignacio I.
Published: April 2023

PDF file - 315K, Sweave Report
Supplementary Table 6 from MicroRNA Molecular Profiles Associated with Diagnosis, Clinicopathologic Criteria, and Overall Survival in Patients with Resectable Pancreatic Ductal Adenocarcinoma
Authors: Jamieson Nigel B. , Morran Douglas C. , Morton Jennifer P. , Ali Asif , Dickson Euan J. , Carter C. Ross , Sansom Owen J. , Evans T.R. Jeffry , McKay Colin J. , Oien Karin A.
Published: April 2023

XLS file - 50K, Multivariate analysis of combined 72 patient cohort. A) All 72 patients. B) 38 patients with low miR-21 expression (less than median expression value). C) 34 patients with high miR-21 expression (greater than median expression).
Supplementary Table 5 from MicroRNA Molecular Profiles Associated with Diagnosis, Clinicopathologic Criteria, and Overall Survival in Patients with Resectable Pancreatic Ductal Adenocarcinoma
Authors: Jamieson Nigel B. , Morran Douglas C. , Morton Jennifer P. , Ali Asif , Dickson Euan J. , Carter C. Ross , Sansom Owen J. , Evans T.R. Jeffry , McKay Colin J. , Oien Karin A.
Published: April 2023

PDF file - 270K, Association of miRNA expression levels measured by RT-PCR with overall survival: univariate analysis.
Supplementary Table S1 from EGFR Fluorescence In situ Hybridization Pattern of Chromosome 7 Disomy Predicts Resistance to Cetuximab in KRAS Wild-type Metastatic Colorectal Cancer Patients
Authors: Li Yu-Hong , Wang Fang , Shen Lin , Deng Yan-Ming , Shao Qiong , Feng Fen , An Xin , Wang Feng-Hua , Wang Zhi-Qiang , Xu Rui-Hua , Shao Jian-Yong
Published: April 2023

Supplementary Table S1.
Supplementary Figure 1 from Prognostic Model for Survival in Patients with Metastatic Renal Cell Carcinoma: Results from the International Kidney Cancer Working Group
Authors: Manola Judith , Royston Patrick , Elson Paul , McCormack Jennifer Bacik , Mazumdar Madhu , Négrier Sylvie , Escudier Bernard , Eisen Tim , Dutcher Janice , Atkins Michael , Heng Daniel Y.C. , Choueiri Toni K. , Motzer Robert , Bukowski Ronald
Published: April 2023

PDF file - 47K
Supplementary Figure 2 from MicroRNA Molecular Profiles Associated with Diagnosis, Clinicopathologic Criteria, and Overall Survival in Patients with Resectable Pancreatic Ductal Adenocarcinoma
Authors: Jamieson Nigel B. , Morran Douglas C. , Morton Jennifer P. , Ali Asif , Dickson Euan J. , Carter C. Ross , Sansom Owen J. , Evans T.R. Jeffry , McKay Colin J. , Oien Karin A.
Published: April 2023

PDF file - 3.2MB, Immunohistochemical staining in PDAC. Immunohistochemistry staining for Bcl-2, maspin, PTEN, p53, cyclin D1 in human normal pancreatic ducts and pancreatic ductal adenocarcinoma with examples of expression of nil, low, moderate, and strong staining.
Supplementary Figure 3 from Synergistic Action of a RAF Inhibitor and a Dual PI3K/mTOR Inhibitor in Thyroid Cancer
Authors: Jin Ning , Jiang Tianyun , Rosen David M. , Nelkin Barry D. , Ball Douglas W.
Published: April 2023

PDF file - 77K
Supplementary Figure 1 from MicroRNA Molecular Profiles Associated with Diagnosis, Clinicopathologic Criteria, and Overall Survival in Patients with Resectable Pancreatic Ductal Adenocarcinoma
Authors: Jamieson Nigel B. , Morran Douglas C. , Morton Jennifer P. , Ali Asif , Dickson Euan J. , Carter C. Ross , Sansom Owen J. , Evans T.R. Jeffry , McKay Colin J. , Oien Karin A.
Published: April 2023

PDF file - 243K, Supervised average linkage clustering with centred Pearson correlation using 48 PDACs and 10 normal pancreatic samples. miRNAs are in rows with the samples in columns. The non-tumor normal pancreatic samples are on the right highlighted in green, with the tumor samples highlighted in blue. The expression color bar is shown below the dendrogram. Red indicates a miRNA expression value higher than the average expression across all samples, while blue indicates a lower expression value.
Supplementary Figure Legend 1 from Selective BRAF Inhibitors Induce Marked T-cell Infiltration into Human Metastatic Melanoma
Authors: Wilmott James S. , Long Georgina V. , Howle Julie R. , Haydu Lauren E. , Sharma Raghwa N. , Thompson John F. , Kefford Richard F. , Hersey Peter , Scolyer Richard A.
Published: April 2023

PDF file - 51K
Supplementary Table 5 from Gene Expression, Molecular Class Changes, and Pathway Analysis after Neoadjuvant Systemic Therapy for Breast Cancer
Authors: Gonzalez-Angulo Ana M. , Iwamoto Takayuki , Liu Shuying , Chen Huiqin , Do Kim-Anh , Hortobagyi Gabriel N. , Mills Gordon B. , Meric-Bernstam Funda , Symmans W. Fraser , Pusztai Lajos
Published: April 2023

XLS file - 250K
Supplementary Table 4 from Gene Expression, Molecular Class Changes, and Pathway Analysis after Neoadjuvant Systemic Therapy for Breast Cancer
Authors: Gonzalez-Angulo Ana M. , Iwamoto Takayuki , Liu Shuying , Chen Huiqin , Do Kim-Anh , Hortobagyi Gabriel N. , Mills Gordon B. , Meric-Bernstam Funda , Symmans W. Fraser , Pusztai Lajos
Published: April 2023

PDF file - 125K
Supplementary Table 4 from Novel Functional Germline Variants in the VEGF Receptor 2 Gene and Their Effect on Gene Expression and Microvessel Density in Lung Cancer
Authors: Glubb Dylan M. , Cerri Elisa , Giese Alexandra , Zhang Wei , Mirza Osman , Thompson Emma E. , Chen Peixian , Das Soma , Jassem Jacek , Rzyman Witold , Lingen Mark W. , Salgia Ravi , Hirsch Fred R. , Dziadziuszko Rafal , Ballmer-Hofer Kurt , Innocenti Federico
Published: April 2023

PDF file - 102K, Summary of KDR genetic variant found after resequencing of 72 healthy subjects of three different ethnicities.
Supplementary Table 2 from Novel Functional Germline Variants in the VEGF Receptor 2 Gene and Their Effect on Gene Expression and Microvessel Density in Lung Cancer
Authors: Glubb Dylan M. , Cerri Elisa , Giese Alexandra , Zhang Wei , Mirza Osman , Thompson Emma E. , Chen Peixian , Das Soma , Jassem Jacek , Rzyman Witold , Lingen Mark W. , Salgia Ravi , Hirsch Fred R. , Dziadziuszko Rafal , Ballmer-Hofer Kurt , Innocenti Federico
Published: April 2023

PDF file - 46K, KDR regions containing dense clusters of transcription factor binding motifs identified by Cluster-Buster.
Related Article from Response to Combined Molecular Targeting: Defining the Role of P-STAT3
Authors: Egloff Ann Marie , Grandis Jennifer R.
Published: April 2023

Related Article from Response to Combined Molecular Targeting: Defining the Role of P-STAT3
Supplementary Table 1 from Novel Functional Germline Variants in the VEGF Receptor 2 Gene and Their Effect on Gene Expression and Microvessel Density in Lung Cancer
Authors: Glubb Dylan M. , Cerri Elisa , Giese Alexandra , Zhang Wei , Mirza Osman , Thompson Emma E. , Chen Peixian , Das Soma , Jassem Jacek , Rzyman Witold , Lingen Mark W. , Salgia Ravi , Hirsch Fred R. , Dziadziuszko Rafal , Ballmer-Hofer Kurt , Innocenti Federico
Published: April 2023

PDF file - 60K, KDR conserved regions determined using comparative genomics analysis in the UCSC Genome Browser.
Supplementary Figure 7 from Novel Functional Germline Variants in the VEGF Receptor 2 Gene and Their Effect on Gene Expression and Microvessel Density in Lung Cancer
Authors: Glubb Dylan M. , Cerri Elisa , Giese Alexandra , Zhang Wei , Mirza Osman , Thompson Emma E. , Chen Peixian , Das Soma , Jassem Jacek , Rzyman Witold , Lingen Mark W. , Salgia Ravi , Hirsch Fred R. , Dziadziuszko Rafal , Ballmer-Hofer Kurt , Innocenti Federico
Published: April 2023

PDF file - 30K, MVD and tumor histology. Panel A shows the log2-transformed MVD percentage of NSCLC samples from different tumor histologies (SCC = squamous cell carcinoma; AC = adenocarcinoma; LCC = large cell carcinoma; NOS = not otherwise specified). In panel B, Group 1 is composed of squamous cell carcinomas and NSCLCs not otherwise specified/mixed; Group 2 is composed of adenocarcinomas and large cell carcinomas. The result of a t-test examining the differences between the two groups is shown.
Supplementary Table 1 from Gender Influences the Class III and V β-Tubulin Ability to Predict Poor Outcome in Colorectal Cancer
Authors: Mariani Marisa , Zannoni Gian Franco , Sioletic Stefano , Sieber Steven , Martino Candice , Martinelli Enrica , Coco Claudio , Scambia Giovanni , Shahabi Shohreh , Ferlini Cristiano
Published: April 2023

PDF file, 39KB, IC50 of the used panel of cell lines.
Supplementary Figure 4 from Novel Functional Germline Variants in the VEGF Receptor 2 Gene and Their Effect on Gene Expression and Microvessel Density in Lung Cancer
Authors: Glubb Dylan M. , Cerri Elisa , Giese Alexandra , Zhang Wei , Mirza Osman , Thompson Emma E. , Chen Peixian , Das Soma , Jassem Jacek , Rzyman Witold , Lingen Mark W. , Salgia Ravi , Hirsch Fred R. , Dziadziuszko Rafal , Ballmer-Hofer Kurt , Innocenti Federico
Published: April 2023

PDF file - 26K, Correlation of VEGFR-2 and KDR mRNA levels.
Supplementary Figure 1 from Gender Influences the Class III and V β-Tubulin Ability to Predict Poor Outcome in Colorectal Cancer
Authors: Mariani Marisa , Zannoni Gian Franco , Sioletic Stefano , Sieber Steven , Martino Candice , Martinelli Enrica , Coco Claudio , Scambia Giovanni , Shahabi Shohreh , Ferlini Cristiano
Published: April 2023

PDF file, 976KB, Representative Immunhistochemistry for TUBB6 PDF (956KB) Source File (PPTX) 2960KB At the top representative immunohistochemistry of a section of normal colon. Normal colonic cells are TUBB6 negative. At the bottom a section coming from a colorectal cancer with 1005 of TUBB6 staining.
Supplementary Tables 1-6 from Distinct Signal Transduction Abnormalities and Erythropoietin Response in Bone Marrow Hematopoietic Cell Subpopulations of Myelodysplastic Syndrome Patients
Authors: Spinelli Elena , Caporale Roberto , Buchi Francesca , Masala Erico , Gozzini Antonella , Sanna Alessandro , Sassolini Francesca , Valencia Ana , Bosi Alberto , Santini Valeria
Published: April 2023

PDF file - 54K, MFI values indicating basal and EPO and G-CSF induced activation of ERK1/2, STAT5, p38 MAPK, and caspase-3 in MDS subpopulations. Correlation between EPO response in vitro and in the clinic
Supplementary Figure 4 from Distinct Signal Transduction Abnormalities and Erythropoietin Response in Bone Marrow Hematopoietic Cell Subpopulations of Myelodysplastic Syndrome Patients
Authors: Spinelli Elena , Caporale Roberto , Buchi Francesca , Masala Erico , Gozzini Antonella , Sanna Alessandro , Sassolini Francesca , Valencia Ana , Bosi Alberto , Santini Valeria
Published: April 2023

PDF file - 52K, Dot plot indicating basal activation of P-ERK1/2, P-STAT5, P-p38 and cleaved caspase-3 in CD71+CD45- MDS and normal cells
Supplementary Table 2 from Defective Mismatch Repair Status as a Prognostic Biomarker of Disease-Free Survival in Stage III Colon Cancer Patients Treated with Adjuvant FOLFOX Chemotherapy
Authors: Zaanan Aziz , Fléjou Jean-François , Emile Jean-François , Des Guetz Gaëtan , Cuilliere-Dartigues Peggy , Malka David , Lecaille Cédric , Validire Pierre , Louvet Christophe , Rougier Philippe , de Gramont Aimery , Bonnetain Franck , Praz Françoise , Taïeb Julien
Published: April 2023

PDF file - 61K
Supplementary Figure 2 from A Phase I Pharmacokinetic and Pharmacodynamic Study of Dalotuzumab (MK-0646), an Anti-Insulin-like Growth Factor-1 Receptor Monoclonal Antibody, in Patients with Advanced Solid Tumors
Authors: Atzori Francesco , Tabernero Josep , Cervantes Andrés , Prudkin Ludmila , Andreu Jordi , Rodríguez-Braun Edith , Domingo Amparo , Guijarro Jorge , Gamez Cristina , Rodon Jordi , Di Cosimo Serena , Brown Holly , Clark Jason , Hardwick James S. , Beckman Robert A. , Hanley William D. , Hsu Karl , Calvo Emiliano , Roselló Susana , Langdon Ronald B. , Baselga José
Published: April 2023

PDF file - 81K
Supplementary Figure 6 from Complex Patterns of Altered MicroRNA Expression during the Adenoma-Adenocarcinoma Sequence for Microsatellite-Stable Colorectal Cancer
Authors: Bartley Angela N. , Yao Hui , Barkoh Bedia A. , Ivan Cristina , Mishra Bal M. , Rashid Asif , Calin George A. , Luthra Rajyalakshmi , Hamilton Stanley R.
Published: April 2023

PDF file - 2.4MB
CCR Translation for This Article from Complex Patterns of Altered MicroRNA Expression during the Adenoma-Adenocarcinoma Sequence for Microsatellite-Stable Colorectal Cancer
Authors: Bartley Angela N. , Yao Hui , Barkoh Bedia A. , Ivan Cristina , Mishra Bal M. , Rashid Asif , Calin George A. , Luthra Rajyalakshmi , Hamilton Stanley R.
Published: April 2023

CCR Translation for This Article from Complex Patterns of Altered MicroRNA Expression during the Adenoma-Adenocarcinoma Sequence for Microsatellite-Stable Colorectal Cancer
Supplementary Figure 6 from Preferential Replication of Systemically Delivered Oncolytic Vaccinia Virus in Focally Irradiated Glioma Xenografts
Authors: Advani Sunil J. , Buckel Lisa , Chen Nanhai G. , Scanderbeg Daniel J. , Geissinger Ulrike , Zhang Qian , Yu Yong A. , Aguilar Richard J. , Mundt Arno J. , Szalay Aladar A.
Published: April 2023

PDF file - 41K
Supplementary Data from Human Monoclonal Antibodies to Sialyl-Lewisa (CA19.9) with Potent CDC, ADCC, and Antitumor Activity
Authors: Sawada Ritsuko , Sun Shu-Man , Wu Xiaohong , Hong Feng , Ragupathi Govind , Livingston Philip O. , Scholz Wolfgang W.
Published: April 2023

Supplementary Figure S1; Supplementary Tables S1-S2.
Supplementary Figure 2 from Preferential Replication of Systemically Delivered Oncolytic Vaccinia Virus in Focally Irradiated Glioma Xenografts
Authors: Advani Sunil J. , Buckel Lisa , Chen Nanhai G. , Scanderbeg Daniel J. , Geissinger Ulrike , Zhang Qian , Yu Yong A. , Aguilar Richard J. , Mundt Arno J. , Szalay Aladar A.
Published: April 2023

PDF file - 104K
Supplementary Table 3 from Upregulated IL-19 in Breast Cancer Promotes Tumor Progression and Affects Clinical Outcome
Authors: Hsing Chung-Hsi , Cheng Hung-Chi , Hsu Yu-Hsiang , Chan Chien-Hui , Yeh Ching-Hua , Li Chien-Feng , Chang Ming-Shi
Published: April 2023

PDF file - 61K
Supplementary Figure Legends 1-3 from Upregulated IL-19 in Breast Cancer Promotes Tumor Progression and Affects Clinical Outcome
Authors: Hsing Chung-Hsi , Cheng Hung-Chi , Hsu Yu-Hsiang , Chan Chien-Hui , Yeh Ching-Hua , Li Chien-Feng , Chang Ming-Shi
Published: April 2023

PDF file - 86K
Supplementary Figure 1D from Notch1 Expression, Which Is Related to p65 Status, Is an Independent Predictor of Prognosis in Colorectal Cancer
Authors: Chu Dake , Zhou Yi , Zhang Zixi , Li Yuming , Li Jipeng , Zheng Jianyong , Zhang Hongwei , Zhao Qingchuan , Wang Weizhong , Wang Rui'an , Ji Gang
Published: April 2023

PDF file - 4662K
Supplementary Figure 2 from Upregulated IL-19 in Breast Cancer Promotes Tumor Progression and Affects Clinical Outcome
Authors: Hsing Chung-Hsi , Cheng Hung-Chi , Hsu Yu-Hsiang , Chan Chien-Hui , Yeh Ching-Hua , Li Chien-Feng , Chang Ming-Shi
Published: April 2023

PDF file - 592K
Supplementary Data from Specifically Targeting Angiopoietin-2 Inhibits Angiogenesis, Tie2-Expressing Monocyte Infiltration, and Tumor Growth
Authors: Huang Hanhua , Lai Jing-Yu , Do Janet , Liu Dingguo , Li Lingna , Del Rosario Joselyn , Doppalapudi Venkata R. , Pirie-Shepherd Steven , Levin Nancy , Bradshaw Curt , Woodnutt Gary , Lappe Rodney , Bhat Abhijit
Published: April 2023

Supplementary Figures S1-S3.
Supplementary Figures 1 - 4 from Aberrant L1 Cell Adhesion Molecule Affects Tumor Behavior and Chemosensitivity in Anaplastic Thyroid Carcinoma
Authors: Kim Koon Soon , Min Jeong-Ki , Liang Zhe Long , Lee Kyungmin , Lee Jung Uee , Bae Kwang-Hee , Lee Min Hee , Lee Seong Eun , Ryu Min Jeong , Kim Soung Jung , Kim Yong Kyoung , Choi Min Jeong , Jo Young Suk , Kim Jin-Man , Shong Minho
Published: April 2023

PDF file, 1016KB, Supplementary Figure 1. Immunohistochemical staining shows L1CAM is expressed in the invasive areas of ATC. Cases 1 through 3 have L1CAM expression in the invasive islands (red arrowhead). Cases 7 and 8 express L1CAM in the invasive fronts of ATC (black arrowhead). Supplementary Figure 2. Aberrant L1CAM expression is observed in recurrent ATC. Case 4 has negative L1CAM expression at the PTC tumor (left). Black arrowhead indicates the internal positive control at the peripheral nerve bundles that has normal L1CAM expression. However, the recurred ATC tumor exhibits positive L1CAM expression in Case 4 (right). Supplementary Figure 3. Immunohistochemical staining of cyclin D1 and p53 in ATC (Original magnification: �200). Supplementary Figure 4. L1CAM expression in primary cultured follicular cells (PCFC), primary cultured PTC (PCPTC), PTC cell lines (TPC1 and BCPAP), and ATC cell lines (FRO and 8505C). The ovarian carcinoma cell line SKOV3 is used as a positive control. Thyroglobulin is a marker of thyroid-derived cells.
Supplementary Table 1 from Targeting ALDHbright Human Carcinoma–Initiating Cells with ALDH1A1-Specific CD8+ T Cells
Authors: Visus Carmen , Wang Yangyang , Lozano-Leon Antonio , Ferris Robert L. , Silver Susan , Szczepanski Miroslaw J. , Brand Randall E. , Ferrone Cristina R. , Whiteside Theresa L. , Ferrone Soldano , DeLeo Albert B. , Wang Xinhui
Published: April 2023

PDF file - 76KB
Supplementary Figure 5 from Targeting ALDHbright Human Carcinoma–Initiating Cells with ALDH1A1-Specific CD8+ T Cells
Authors: Visus Carmen , Wang Yangyang , Lozano-Leon Antonio , Ferris Robert L. , Silver Susan , Szczepanski Miroslaw J. , Brand Randall E. , Ferrone Cristina R. , Whiteside Theresa L. , Ferrone Soldano , DeLeo Albert B. , Wang Xinhui
Published: April 2023

PDF file - 168KB
Supplementary Figure 3c from Targeting ALDHbright Human Carcinoma–Initiating Cells with ALDH1A1-Specific CD8+ T Cells
Authors: Visus Carmen , Wang Yangyang , Lozano-Leon Antonio , Ferris Robert L. , Silver Susan , Szczepanski Miroslaw J. , Brand Randall E. , Ferrone Cristina R. , Whiteside Theresa L. , Ferrone Soldano , DeLeo Albert B. , Wang Xinhui
Published: April 2023

PDF file - 43KB
Supplementary Figure 5 from Mutations in the Ras–Raf Axis Underlie the Prognostic Value of CD133 in Colorectal Cancer
Authors: Kemper Kristel , Versloot Miranda , Cameron Katherine , Colak Selçuk , de Sousa e Melo Felipe , de Jong Joan H. , Bleackley Joanne , Vermeulen Louis , Versteeg Rogier , Koster Jan , Medema Jan Paul
Published: April 2023

PDF file, 591KB, Gene set enrichment analysis CD133 high vs low.
Supplementary Figure 3a from Targeting ALDHbright Human Carcinoma–Initiating Cells with ALDH1A1-Specific CD8+ T Cells
Authors: Visus Carmen , Wang Yangyang , Lozano-Leon Antonio , Ferris Robert L. , Silver Susan , Szczepanski Miroslaw J. , Brand Randall E. , Ferrone Cristina R. , Whiteside Theresa L. , Ferrone Soldano , DeLeo Albert B. , Wang Xinhui
Published: April 2023

PDF file - 59KB
Supplementary Materials and Methods from Sorafenib Is an Inhibitor of UGT1A1 but Is Metabolized by UGT1A9: Implications of Genetic Variants on Pharmacokinetics and Hyperbilirubinemia
Authors: Peer Cody J. , Sissung Tristan M. , Kim AeRang , Jain Lokesh , Woo Sukyung , Gardner Erin R. , Kirkland C. Tyler , Troutman Sarah M. , English Bevin C. , Richardson Emily D. , Federspiel Joel , Venzon David , Dahut William , Kohn Elise , Kummar Shivaani , Yarchoan Robert , Giaccone Giuseppe , Widemann Brigitte , Figg William D.
Published: April 2023

PDF file - 191K
Supplementary Table 1 from Insulin-like Growth Factor–Binding Protein-7 Functions as a Potential Tumor Suppressor in Hepatocellular Carcinoma
Authors: Chen Dong , Yoo Byoung Kwon , Santhekadur Prasanna Kumar , Gredler Rachel , Bhutia Sujit K. , Das Swadesh K. , Fuller Christine , Su Zao-zhong , Fisher Paul B. , Sarkar Devanand
Published: April 2023

PDF file - 46KB
Supplementary Figure 1 from Insulin-like Growth Factor–Binding Protein-7 Functions as a Potential Tumor Suppressor in Hepatocellular Carcinoma
Authors: Chen Dong , Yoo Byoung Kwon , Santhekadur Prasanna Kumar , Gredler Rachel , Bhutia Sujit K. , Das Swadesh K. , Fuller Christine , Su Zao-zhong , Fisher Paul B. , Sarkar Devanand
Published: April 2023

PDF file - 423KB
Supplementary Table 1 from Loss of Transforming Growth Factor Beta Type II Receptor Increases Aggressive Tumor Behavior and Reduces Survival in Lung Adenocarcinoma and Squamous Cell Carcinoma
Authors: Malkoski Stephen P. , Haeger Sarah M. , Cleaver Timothy G. , Rodriguez Karen J. , Li Howard , Lu Shi-Long , Feser William J. , Barón Anna E. , Merrick Daniel , Lighthall Jessyka G. , Ijichi Hideaki , Franklin Wilbur , Wang Xiao-Jing
Published: April 2023

PDF file - 787K
Supplementary Figure 6 from Loss of Transforming Growth Factor Beta Type II Receptor Increases Aggressive Tumor Behavior and Reduces Survival in Lung Adenocarcinoma and Squamous Cell Carcinoma
Authors: Malkoski Stephen P. , Haeger Sarah M. , Cleaver Timothy G. , Rodriguez Karen J. , Li Howard , Lu Shi-Long , Feser William J. , Barón Anna E. , Merrick Daniel , Lighthall Jessyka G. , Ijichi Hideaki , Franklin Wilbur , Wang Xiao-Jing
Published: April 2023

PDF file - 8.6MB
Supplementary Figure 5 from Loss of Transforming Growth Factor Beta Type II Receptor Increases Aggressive Tumor Behavior and Reduces Survival in Lung Adenocarcinoma and Squamous Cell Carcinoma
Authors: Malkoski Stephen P. , Haeger Sarah M. , Cleaver Timothy G. , Rodriguez Karen J. , Li Howard , Lu Shi-Long , Feser William J. , Barón Anna E. , Merrick Daniel , Lighthall Jessyka G. , Ijichi Hideaki , Franklin Wilbur , Wang Xiao-Jing
Published: April 2023

PDF file - 694K
Supplementary Figure 4 from Loss of Transforming Growth Factor Beta Type II Receptor Increases Aggressive Tumor Behavior and Reduces Survival in Lung Adenocarcinoma and Squamous Cell Carcinoma
Authors: Malkoski Stephen P. , Haeger Sarah M. , Cleaver Timothy G. , Rodriguez Karen J. , Li Howard , Lu Shi-Long , Feser William J. , Barón Anna E. , Merrick Daniel , Lighthall Jessyka G. , Ijichi Hideaki , Franklin Wilbur , Wang Xiao-Jing
Published: April 2023

PDF file - 7.4MB
Supplementary Table 1 from Survival of 1,181 Patients in a Phase I Clinic: The MD Anderson Clinical Center for Targeted Therapy Experience
Authors: Wheler Jennifer , Tsimberidou Apostolia M. , Hong David , Naing Aung , Falchook Gerald , Piha-Paul Sarina , Fu Siqing , Moulder Stacy , Stephen Bettzy , Wen Sijin , Kurzrock Razelle
Published: April 2023

PDF file, 72KB, Comparison of prognostic models: the MDACC score vs. the RMH score showing number of patients by variable (p<0.00001).
Supplementary Tables 1-2 from Bexarotene via CBP/p300 Induces Suppression of NF-κB–Dependent Cell Growth and Invasion in Thyroid Cancer
Authors: Cras Audrey , Politis Béatrice , Balitrand Nicole , Darsin-Bettinger Diane , Boelle Pierre Yves , Cassinat Bruno , Toubert Marie-Elisabeth , Chomienne Christine
Published: April 2023

PDF file - 96K
Supplementary Figure 2A from Survival of 1,181 Patients in a Phase I Clinic: The MD Anderson Clinical Center for Targeted Therapy Experience
Authors: Wheler Jennifer , Tsimberidou Apostolia M. , Hong David , Naing Aung , Falchook Gerald , Piha-Paul Sarina , Fu Siqing , Moulder Stacy , Stephen Bettzy , Wen Sijin , Kurzrock Razelle
Published: April 2023

PDF file, 96KB, Kaplan - Meier survival curves by dichotomized MDACC score (n=1,153 patients for whom all baseline data points were available). Median survival is 13.7months (95% CI: 12.1 - 15.5) for MDACC score ≤2, and 5.7 months (95% CI: 6.3 - 7.4) for MDACC score >2 (Log-rank p-value<0.0001).
Supplementary Figure 2 from Significant Biological Role of Sp1 Transactivation in Multiple Myeloma
Authors: Fulciniti Mariateresa , Amin Samir , Nanjappa Puru , Rodig Scott , Prabhala Rao , Li Cheng , Minvielle Stephane , Tai Yu-tzu , Tassone Pierfrancesco , Avet-Loiseau Herve , Hideshima Teru , Anderson Kenneth C. , Munshi Nikhil C.
Published: April 2023

PDF file - 48KB
Supplementary Figure 1A from Survival of 1,181 Patients in a Phase I Clinic: The MD Anderson Clinical Center for Targeted Therapy Experience
Authors: Wheler Jennifer , Tsimberidou Apostolia M. , Hong David , Naing Aung , Falchook Gerald , Piha-Paul Sarina , Fu Siqing , Moulder Stacy , Stephen Bettzy , Wen Sijin , Kurzrock Razelle
Published: April 2023

PDF file, 95KB, Kaplan - Meier survival curves by albumin levels (n=1,174 patients for whom albumin levels were available). Median survival is 10.9 months (95% CI: 10.1 - 12.0) for albumin <3.5 g/dL, and 5.4 months (95% CI: 3.9 - 6.8) for albumin ≥3.5 g/dL (Log-rank p-value <0.0001).
Conflict of Interest Form 1 from Upregulation of Rac GTPase-Activating Protein 1 Is Significantly Associated with the Early Recurrence of Human Hepatocellular Carcinoma
Authors: Wang Suk Mei , Ooi London Lucien P.J. , Hui Kam M.
Published: April 2023

Conflict of Interest Form 1 from Upregulation of Rac GTPase-Activating Protein 1 Is Significantly Associated with the Early Recurrence of Human Hepatocellular Carcinoma
CCR Translation for This Article from The Use and Interpretation of Competing Risks Regression Models
Authors: Dignam James J. , Zhang Qiang , Kocherginsky Masha
Published: April 2023

CCR Translation for This Article from The Use and Interpretation of Competing Risks Regression Models
Supplementary Figure 1 from Lenalidomide-Induced Immunomodulation in Multiple Myeloma: Impact on Vaccines and Antitumor Responses
Authors: Noonan Kimberly , Rudraraju Lakshmi , Ferguson Anna , Emerling Amy , Pasetti Marcela F. , Huff Carol A. , Borrello Ivan
Published: April 2023

PDF file - 43K
Supplementary Figure 1 from Tumor-Derived Autophagosome Vaccine: Induction of Cross-Protective Immune Responses against Short-lived Proteins through a p62-Dependent Mechanism
Authors: Twitty Christopher G. , Jensen Shawn M. , Hu Hong-Ming , Fox Bernard A.
Published: April 2023

PDF file - 44K, Irradiated whole cell sarcoma-pulsed APCs do not protect mice from a challenge with non-homologous sarcomas. Kaplan-Meier survival curves of mice vaccinated with irradiated whole cell sarcoma-pulsed APCs or autophagosome-pulsed APCs. Autophagosome vaccination was performed as in Figure 2. Subcutaneous whole cell vaccinations consisted of 3x106 antigen-presenting cells pulsed with 5x106 irradiated tumor cells injected into the lower right flank of the mouse. Mice were challenged with 30,000 viable MCA-304 sarcomas. Tumor growth was monitored at least twice weekly. Each survival plot represents 2 independent experiments with 5 mice per group (n=10). Survival curves denoted with � represent statistically significant (p>0.05) protection from a tumor challenge compared to no vaccine.
Supplementary Figure 4 from A Novel Aldehyde Dehydrogenase-3 Activator Leads to Adult Salivary Stem Cell Enrichment In Vivo
Authors: Banh Alice , Xiao Nan , Cao Hongbin , Chen Che-Hong , Kuo Peiwen , Krakow Trevor , Bavan Brindha , Khong Brian , Yao Mike , Ha Chi , Kaplan Michael J. , Sirjani Davud , Jensen Kristin , Kong Christina S. , Mochly-Rosen Daria , Koong Albert C. , Le Quynh-Thu
Published: April 2023

PDF file - 187K
Supplementary Figure 2 from A Novel Aldehyde Dehydrogenase-3 Activator Leads to Adult Salivary Stem Cell Enrichment In Vivo
Authors: Banh Alice , Xiao Nan , Cao Hongbin , Chen Che-Hong , Kuo Peiwen , Krakow Trevor , Bavan Brindha , Khong Brian , Yao Mike , Ha Chi , Kaplan Michael J. , Sirjani Davud , Jensen Kristin , Kong Christina S. , Mochly-Rosen Daria , Koong Albert C. , Le Quynh-Thu
Published: April 2023

PDF file - 215K